A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies

British Journal of Cancer

Volumn 74, Issue 2, 1996, Pages 269-273

  Speiser, P ^a,f   Gharehbaghi Schnell, E ^a   Eder, S ^a   Haid, A ^b   Kovarik J ^c   Nenutil, R ^c   Sauter, G ^d   Schneeberger, C H ^a   Vojtesek, B ^c   Wiltschke, C H ^e   Zeillinger, R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b GENERAL HOSPITAL KLAGENFURT   (Austria)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^d UNIVERSITY OF BASEL   (Switzerland)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f Department of Obstetrics and Gynecology ^*  (Austria)

Author keywords

Genetic instability; Germ line; Immunohistochemistry; p53

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT FIBROUS HISTIOCYTOMA; MULTIPLE CANCER; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030016202     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.350     Document Type: Article

References (27)

1. BIRCH JM, HARTLEY AL, TRICKER KJ, PROSSER J, CONDIE A, KELSEY AM, HARRIS M, JONES PH, BINCHY A, CROWTHER D, CROWTHER D, CRAFT AW, EDEN OB, EVANS GR, THOMPSON E, MANN JR, MARTIN J, MITCHELL LD AND SANTIBANEZ-KOREF MF. (1994). Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res., 54, 1298-1304.
2. CARON DE FROMENTEL C AND SOUSSI T. (1992). TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chrom. Cancer, 4, 1-15.
3. CHO Y, GORINA S, JEFFREY PD AND PAVLETICH NP. (1994). Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355.
4. EELES RA, WARREN W, KNEE G, BARTEK J, AVERILL D, STRATTON MR, BLAKE PR, TAIT DM, LANE DP, EASTON DF, YARNOLD JR, COOPER CS AND SLOANE JP. (1993). Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. Oncogene, 8, 1269-1276.
5. GREENWALD BD, HARPAZ N, YIN J, HUANG Y, TONG Y, BROWN VL, MCDANIEL T, NEWKIRK C, RESAU JH AND MELTZER SJ. (1992). Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res., 52, 741-745.
6. GYAPAY G, MORISSETTE J, VIGNAL A, DIB C, FIZAMES C, MILLAUSSEAU P, MARC S, BERNARDI G, LATHROP M AND WEISSENBACH J. (1994). The 1993-94 Genethon human genetic linkage map. Nature Genet., 7, 246-339.
7. HOLLSTEIN M, RICE K, GREENBLATT MS, SOUSSI T, FUCHS R, SORLIE T, HOVIG E, SMITH SORENSEN B, MONTESANO R AND HARRIS CC. (1994). Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res., 12, 3551-3555.
8. HOLLSTEIN MC, METCALF RA, WELSH JA, MONTESANO R AND HARRIS CC. (1990). Frequent mutation of the p53 gene in human esophageal cancer. Proc. Natl Acad. Sci. USA, 87, 9958-9961.
9. JONES MH AND NAKAMURA Y. (1992). Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chrom. Cancer, 5, 89-90.
10. KNUDSON AG. (1985). Hereditary cancer, oncogenes, and anti-oncogenes. Cancer Res., 45, 1437-1443.
11. LANE DP. (1992). p53, guardian of the genome. Nature, 358, 15-16.
12. LEVINE AJ, MOMAND J AND FINLAY CA. (1991). The p53 tumour suppressor gene. Nature, 351, 453-456.
13. LI FP AND FRAUMENI JFJ. (1969). Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann. Intern. Med., 71, 747-752.
14. MALKIN D, LI FP, STRONG LC, FRAUMENIJF Jr, NELSON CE, KIM DH, KASSEL J, GRYKA MA, BISCHOFF FZ, TAINSKY M AND FRIEND SH. (1990). Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233-1238.
15. MIDGLEY CA, FISHER CJ, BARTER J, VOJTESEK B, LANE D AND BARNES DM. (1992). Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J. Cell. Sci., 101, 183-189.
16. MOMAND J, ZAMBETTI GP, OLSON DC, GEORGE D AND LEVINE, AJ. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
17. OLINER JD, KINZLER KW, MELTZER PS, GEORGE DL AND VOGELSTEIN, B. (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature, 358, 80-83.
18. SAMESHIMA Y, MATSUNO Y, HIROHASHI S, SHIMOSATO Y, MIZOGUCHI H, SUGIMURA T, TERADA M AND YOKOTA J. (1992). Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene, 7, 451-457.
19. SAUTER G, MOCH H, CARROLL P, KERSCHMANN R, MIHATSCH MJ AND WALDMANN FW. (1995a). Chromosome-9 loss detected by fluorescence in situ hybridisation in bladder cancer. Int. J. Cancer, 64, 99-103.
20. SAUTER G, MOCH H, GASSER TH, MIHATSCH MJ AND WALDMAN FM. (1995b). Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. Cytometry, 21, 40-46.
21. SHEFFIELD VC, COX DR, LERMAN LS AND MYERS RM. (1989). Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragment by the polymerase chain reaction results in improved detection of single-base changes. Proc. Natl Acad. Sci. USA, 86, 232-236.
22. SOUSSI T, CARON DE FROMENTEL C AND MAY P. (1990). Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5, 945-952.
23. SPEISER P, GHAREHBAGHI-SCHNELL E, SCHNEEBERGER C, EDER S AND ZEILLINGER R. (1996). Microdissection as a means to verify allelic imbalance in tumor biopsy samples. Anticancer Res., 16, 461-464.
24. SRIVASTAVA S, ZOU ZQ, PIROLLO K, BLATTNER W AND CHANG EH. (1990). Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature, 348, 747-749.
25. VOGELSTEIN B AND KINZLER KW. (1992). p53 function and dysfunction. Cell, 70, 523-526.
26. VOJTESEK B, BARTEK J, MIDGLEY CA AND LANE DP. (1992). An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J. Immunol. Methods, 151, 237-244.
27. ZAKUT HOURI R, BIENZ TADMOR B, GIVOL D AND OREN M. (1985). Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO J., 4, 1251-1255.